Literature DB >> 28381189

Periostin promotes migration and invasion of renal cell carcinoma through the integrin/focal adhesion kinase/c-Jun N-terminal kinase pathway.

Sun Chuanyu1, Zhu Yuqing2, Xu Chong2, Xia Guowei1, Zhao Xiaojun2.   

Abstract

Periostin (POSTN) is an extracellular matrix protein which is overexpressed in a variety of cancers and has been related to tumorigenesis of renal cell carcinoma. However, the involvement of POSTN in renal cell carcinoma migration, invasion, and their underlying mechanisms has not been established. In this study, renal cell carcinoma cell lines stably overexpressing POSTN were established using a lentiviral vector, and the effects of POSTN on renal cell carcinoma cell migration and invasion were investigated. POSTN overexpression increased the migration and invasion capabilities of renal cell carcinoma cell lines as well as activity of matrix metalloproteinase-2 and matrix metalloproteinase-9. Integrin αvβ3 and αvβ5 antibodies inhibited POSTN overexpression or recombinant POSTN-induced focal adhesion kinase activation, cell migration, and invasion. Furthermore, lentivirus-mediated focal adhesion kinase knockdown and c-Jun N-terminal kinase inhibitor reduced POSTN-enhanced phosphorylation of c-Jun N-terminal kinase, matrix metalloproteinase-9 and matrix metalloproteinase-2 expressions, cell migration, and invasion. Our research thus indicates that POSTN promotes renal cell carcinoma cell migration and invasion through interaction with integrins αvβ3 and αvβ5 and subsequent activation of the focal adhesion kinase/c-Jun N-terminal kinase pathway. These results suggest that POSTN plays a critical role in renal cell carcinoma metastasis and may represent a potential target for novel therapeutic approaches against renal cell carcinoma.

Entities:  

Keywords:  Periostin; cell invasion; cell migration; focal adhesion kinase/c-Jun N-terminal kinase pathway; integrin; renal cell carcinoma

Mesh:

Substances:

Year:  2017        PMID: 28381189     DOI: 10.1177/1010428317694549

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  10 in total

1.  Therapeutic Potential of Targeting Periostin in the Treatment of Graves' Orbitopathy.

Authors:  Sun Young Jang; Jinjoo Kim; Jung Tak Park; Catherine Y Liu; Bobby S Korn; Don O Kikkawa; Eun Jig Lee; Jin Sook Yoon
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-30       Impact factor: 6.055

2.  Biological analysis of cancer specific microRNAs on function modeling in osteosarcoma.

Authors:  Hao Wang; Min Tang; Liping Ou; Mengyi Hou; Tianyu Feng; Yu-E Huang; Yaqian Jin; Heng Zhang; Guowei Zuo
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

Review 3.  Fascinating Fasciclins: A Surprisingly Widespread Family of Proteins that Mediate Interactions between the Cell Exterior and the Cell Surface.

Authors:  Georg J Seifert
Journal:  Int J Mol Sci       Date:  2018-05-31       Impact factor: 5.923

Review 4.  Periostin: A Matricellular Protein With Multiple Functions in Cancer Development and Progression.

Authors:  Laura González-González; Javier Alonso
Journal:  Front Oncol       Date:  2018-06-12       Impact factor: 6.244

5.  Integrative Radiogenomics Approach for Risk Assessment of Post-Operative Metastasis in Pathological T1 Renal Cell Carcinoma: A Pilot Retrospective Cohort Study.

Authors:  Hye Won Lee; Hwan-Ho Cho; Je-Gun Joung; Hwang Gyun Jeon; Byong Chang Jeong; Seong Soo Jeon; Hyun Moo Lee; Do-Hyun Nam; Woong-Yang Park; Chan Kyo Kim; Seong Il Seo; Hyunjin Park
Journal:  Cancers (Basel)       Date:  2020-04-02       Impact factor: 6.639

6.  Tumor- and Osteoblast-Derived Periostin in Prostate Cancer bone Metastases.

Authors:  Chuan-Yu Sun; Yuan-Yuan Mi; Sheng-Yang Ge; Qing-Feng Hu; Ke Xu; Yi-Jun Guo; Yi-Fan Tan; Yang Zhang; Fan Zhong; Guo-Wei Xia
Journal:  Front Oncol       Date:  2022-01-11       Impact factor: 6.244

Review 7.  Periostin in Allergy and Inflammation.

Authors:  Eva Sonnenberg-Riethmacher; Michaela Miehe; Dieter Riethmacher
Journal:  Front Immunol       Date:  2021-08-27       Impact factor: 7.561

8.  Role of Periostin Expression in Non-Small Cell Lung Cancer: Periostin Silencing Inhibits the Migration and Invasion of Lung Cancer Cells via Regulation of MMP-2 Expression.

Authors:  Katarzyna Ratajczak-Wielgomas; Alicja Kmiecik; Piotr Dziegiel
Journal:  Int J Mol Sci       Date:  2022-01-22       Impact factor: 5.923

9.  POSTN promotes proliferation and epithelial-mesenchymal transition in renal cell carcinoma through ILK/AKT/mTOR pathway.

Authors:  Yuan-Yuan Jia; Yue Yu; Hong-Jun Li
Journal:  J Cancer       Date:  2021-05-13       Impact factor: 4.207

10.  PRC1 promotes cell proliferation and cell cycle progression by regulating p21/p27-pRB family molecules and FAK-paxillin pathway in non-small cell lung cancer.

Authors:  Zhigang Liang; Xinjian Li; Jian Chen; Haina Cai; Liqun Zhang; Chenwei Li; Jingjie Tong; Wentao Hu
Journal:  Transl Cancer Res       Date:  2019-09       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.